Journal of Health Care Compliance
Looking Ahead: DOJ Enforcement Priorities in 2025
November – December 2024
In 2024, the Department of Justice (DOJ) continued to emerge from a pandemic lull and return to vigorous enforcement of the False Claims Act (FCA) — indeed in February, DOJ announced that it had issued a record 1,504 civil investigative demands in fiscal year 2023, and its current activity levels suggest another record-breaking year. In 2025, the healthcare industry can expect that DOJ will continue to prioritize investigating alleged fraud, waste, and abuse in the industry, with particular attention paid to private equity investment, the Anti-Kickback Statute (AKS), pandemic relief fraud, and cyber fraud.
Related Blogs
Capabilities
Suggested News & Insights
Ninth Circuit Opens Door to FCA Liability for Alleged 340B OverchargesMarch 19, 2026Fourth Circuit Highlights Tougher Path to Dismissal of FCA Cases Post-SuperValuMarch 18, 2026Fifth Circuit Panel Produces Three Opinions Wrestling with Application of First to File BarMarch 13, 2026Sidley Wins a Trio of Awards at the 2026 Benchmark Litigation US AwardsMarch 12, 2026Strictly Enforcing Rule 9(b), Second Circuit Affirms Dismissal of FCA Claim Based on Allegedly Defective Medical DevicesMarch 4, 2026Court Grants Motion to Dismiss FCA Claim for Failure Adequately to Plead ScienterMarch 3, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
